In recent years, driven by multiple factors such as population aging, new technology advancements, and national policy support, the pharmaceutical industry has ushered in a period of change and opportunities for development. Innovative drug research and development has become the winning point for major pharmaceutical companies seeking development breakthroughs. In this context, COP bottles used for high-end drug packaging will also usher in a period of market growth.
The increase in population aging has led to an increasing demand for innovative drugs by elderly patients. In addition to the introduction of medical policies, such as medical insurance, mass procurement, and consistency evaluation of generic drugs, generic drugs have entered the era of low profits, and closed drug companies have embarked on high-end generic drugs. The road of transformation focusing on research and development of pharmaceuticals and innovative drugs. On the other hand, the state has successively issued various policies to open up the accelerated channels for review and approval of innovative drugs, conditional approval and listing, breakthrough therapeutic drug procedures, etc., optimize procedures, improve efficiency, comprehensively accelerate the development of local innovative drugs, and benchmark international market.
Throughout all kinds of innovative drugs, tumor immunotherapy, nervous system targeted drugs, and gene technology have always been hot areas of research and development. These drugs have high added value and high requirements for dosage accuracy. Some of them are protein drugs. While the packaging meets the basic needs, it should also have the characteristics of low protein adsorption to ensure the drug dosage. Among various packaging materials, COP bottles with excellent performance have become the best choice for most innovative drug packaging.
COP bottle is a new type of drug packaging. It has the characteristics of low birefringence, high transparency, low protein adsorption, non-discoloration by irradiation, and low water absorption. It is suitable for some anti-cancer, anti-tumor, rheumatic, protein and other high The packaging of value-added drugs, and these drugs have always been the focus of innovative drug research and development. As the research and development of domestic innovative drugs gradually enters the better stage, the future market demand for COP bottles will also increase, and the prospect is promising.
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
MAKE AN ENQUIRY
